Logo CICANCER

CIC Events

Application of MALDI-TOF mass spectrometry for the diagnosis and monitoring of patients with multiple myeloma. 06/02/2025

Application of MALDI-TOF mass spectrometry for the diagnosis and monitoring of patients with multiple myeloma.

Cristina Agullo Roca — Centro de Investigación del Cáncer (CSIC-USAL), Hospital Universitario de Salamanca

Unraveling RNA modifications dynamics in prostate cancer progression at single-cell resolution 13/02/2025

Unraveling RNA modifications dynamics in prostate cancer progression at single-cell resolution

Ana Añazco Guenkova — Centro de Investigación del Cáncer. Universidad de Salamanca - CSIC

Mechanisms of dedifferentiation: Linking injury-induced plasticity to cancer initiation 20/02/2025

Mechanisms of dedifferentiation: Linking injury-induced plasticity to cancer initiation

Miguel Bernabé Rubio — King’s College London, UK

Understanding mechanism of efficacy and resistance of CAR-T cell therapies in cancer 27/02/2025

Understanding mechanism of efficacy and resistance of CAR-T cell therapies in cancer

Felipe Prosper — Head of the Hematology and Cell Therapy Department, University of Navarra



Past Events

Novel immunophenotypic approaches to improve the diagnostic classification of mature T-cell neoplasms 30/01/2025

Novel immunophenotypic approaches to improve the diagnostic classification of mature T-cell neoplasms

Javier Morán Plata — Centro de Investigación del Cáncer. Universidad de Salamanca - CSIC

Evolution of 3D chromatin organization in metazoan species 23/01/2025

Evolution of 3D chromatin organization in metazoan species

Darío G. Lupiáñez — Centro Andaluz de Biología del Desarrollo (CABD), CSIC/UPO/JA, Seville, Spain

Decoding the origins of childhood cancer 16/01/2025

Decoding the origins of childhood cancer

Alexandra Avgustinova — Institut de Recerca Sant Joan de Déu and IRB Barcelona

The Humoral Immune landscape of Chronic Lymphocytic Leukemia: biological implications and clinical impact 09/01/2025

The Humoral Immune landscape of Chronic Lymphocytic Leukemia: biological implications and clinical impact

Pablo Juanes-Velasco — Centro de Investigación del Cáncer. Universidad de Salamanca - CSIC